Welcome to the August 7 edition of ‘Pathways’ Picks,’ our MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: CMS has been busy in the past week rolling out policy proposals. We spotlight a few key takeaways for medtech. And more to watch from China, the US, and Germany.
Welcome to the July 24 edition of ‘Pathways Picks’, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: a gathering on device interoperability, a global focus on cybersecurity and software oversight, assessing tech assessment, and more. Download a copy of the first issue of Market Pathways and look for updates here.
“Reverse Chocolate for Dry Eye” Los Angeles-based start-up, AesculaTech, Inc., is developing a platform of temperature-responsive smart materials, including their first product, AesculaGel, a punctal plug for the treatment of dry eye syndrome that is applied as a liquid then solidifies at body temperature and blocks tear ducts. In this interview, co-founder Andrew Bartynski talks about his experiences in getting the company and its technology where it is and what’s next for AesculaTech.
Welcome to the July 10 edition of ‘Pathways Picks’, our MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: Elizabeth Warren watches the device space, China pilots UDI, another notified body bows out and more. Download a copy of the first issue of Market Pathways and look for updates here.
“Robots Hug the Heart for HF Relief” Houston-based start-up, CorInnova Inc., is developing a minimally invasive soft robotic cardiac device that they anticipate will shift the paradigm of existing heart failure (HF) treatments, and may reverse the progression of HF or even prevent its development in post-heart attack patients. In this interview, CEO William Altman and Senior Biomedical Engineer Christina Bolch talk about their experiences in getting the company and its technology where it is and what’s next for CorInnova.
“VerteCore: Wearable Spinal Decompression” Mississippi medical device start-up, VerteCore Technologies LLC, has developed VerteCore Lift, a wearable orthopedic device, to innovate the way back pain is managed. The device alleviates nerve root impingement related sciatica and neurogenic intermittent claudication that results from spinal stenosis with mobile, non-surgical decompression. In this interview, co-founder and CEO, Paul Leake talks about his experiences in co-founding the company and what’s next for VerteCore.
“LabReady, Set, Go: Accurately Diagnosing Infections Faster and From Home” Houston medical device diagnostics start-up, Vax-Immune Diagnostics LLC, has developed LabReady, a hand-held, portable, disposable device. This novel diagnostic platform device was designed to revolutionize the identification process of infectious disease. In this interview, co-founder, President, and CTO Leonard Weisman, MD talks about his experiences in co-founding the company and what’s next for Vax-Immune.
“A Hole in the Heart Alleviates HF Symptoms” Houston medical device start-up, Alleviant Medical, is developing a novel transcatheter technology that applies left atrial decompression to provide symptomatic relief for congestive heart failure. In this interview, co-founder and CMO Jacob Kriegel, MD talks about his experiences in co-founding the company and what’s next for Alleviant Medical.
“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
“OtoSet: Sonicare for the Ears” An Arizona-based medical device start-up SafKan Inc is pursuing an alternative to the current standard-of-care for excess or impacted earwax— unchallenged for nearly two centuries—with the world’s first automated ear cleaning device for clinical use, the OtoSet. In this interview, co-founder and CEO Sahil Diwan talks about his experiences in co-founding the company and what’s next for SafKan.
“When One Door Closes Another Door Opens: The Story of Telluride Medical Partners.” Emerging Arizona-based medical device accelerator Telluride Medical Partners LLC (TMP) is comprised of business entrepreneurs, medical device start-up experts, and medtech engineers who are committed to bringing disruptive technologies to market. In this candid interview, Founder and CEO Eric Wells talks about his early career, his experiences in founding the company, and what’s next for TMP.
In this new installment of his series of interviews on corporate governance in medtech, DeNovo Ventures’ Managing Director Joe Mandato speaks with Jay Watkins, also a Managing Director at De Novo Ventures and at Curation Capital. Jay has served in multiple board roles and shares his insights on what makes a good board tick.
“Sana’s Wearable Solution for Chronic Pain” Boulder, CO-based start-up Sana Health is taking on one of the biggest health crises in the world today: opioid use, as part of a larger mission to redefine the way pain is treated. Sana’s novel FlowState technology induces deep relaxation, promotes neuroplasticity, reduces pain, and triggers sleep in as little as 10 minutes. In this interview, Founder Richard Hanbury talks about his experiences in founding the company and what’s next for Sana Health.
As noted in previous posts here on the Community Blog, dialysis is a therapy whose time has come, and disruptive innovation is needed. In a first-of-its-kind partnership between the US Department of Health and Human Services and the American Society of Nephrology, the ongoing KidneyX: Redesign Dialysis prize competition is looking to spur medtech innovation that completely disrupts the way kidney failure is treated.
Driven by his passion to take care of the people who willingly put their lives on the line, Medical Technology Enterprise Consortium’s COO, William Howell, talks to the Community Blog about the goals of MTEC, and cutting-edge biomedical research that has recently received funding through this US Army organization. Although research is primarily focused on restoring function to severely injured soldiers, many of the medical technologies originally developed by or with funding support from the US military are also impacting the lives of millions of civilian patients.